Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

ABT holding history

Abbott Laboratories in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
13,423,080
Value
$1.22B
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,423,080$1.22B0.1%+2,577,765+23.8%AddedHolders
Q1 202610,845,315$1.11B0.1%+1,217,952+12.7%AddedHolders
Q4 20259,627,363$1.21B0.1%−1,965,231−17.0%ReducedHolders
Q3 202511,592,594$1.55B0.1%−1,971,491−14.5%ReducedHolders
Q2 202513,564,085$1.84B0.1%+2,888,754+27.1%AddedHolders
Q1 202510,675,331$1.42B0.1%+1,561,711+17.1%AddedHolders
Q4 20249,113,620$1.03B0.1%−168,669−1.8%ReducedHolders
Q3 20249,282,289$1.06B0.1%−598,841−6.1%ReducedHolders
Q2 20249,881,130$1.03B0.1%+1,928,789+24.3%AddedHolders
Q1 20247,952,341$903.9M0.1%+347,192+4.6%AddedHolders
Q4 20237,605,149$837.1M0.1%+1,521,106+25.0%AddedHolders
Q3 20236,084,043$589.2M0.1%−786,818−11.5%ReducedHolders
Q2 20236,870,861$749.1M0.1%−736,598−9.7%ReducedHolders
Q1 20237,607,459$770.3M0.1%−1,512,560−16.6%ReducedHolders
Q4 20229,120,019$1.00B0.1%−1,513,187−14.2%ReducedHolders
Q3 202210,633,206$1.03B0.1%−1,744,125−14.1%ReducedHolders
Q2 202212,377,331$1.34B0.1%−549,611−4.3%ReducedHolders
Q1 202212,926,942$1.53B0.1%−1,402,645−9.8%ReducedHolders
Q4 202114,329,587$2.02B0.1%+506,605+3.7%AddedHolders
Q3 202113,822,982$1.63B0.1%−387,954−2.7%ReducedHolders
Q2 202114,210,936$1.65B0.1%−6,198,801−30.4%ReducedHolders
Q1 202120,409,737$2.45B0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.